Hikma Pharmaceutical reported 616M in Gross Profit on Sales for its first fiscal semester of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
AstraZeneca AZN:LN 6.04B 15M
Bayer BAYN:GR 5.89B 414M
Fresenius FRE:GR € 2523M 95M
Fresenius Medical Care FMS:US $ 1267M 16.99M
GlaxoSmithKline GSK:LN 6.26B 682M
GRIFOLS GRF:SM € 580.8M 47.47M
H. Lundbeck A/S LUN:DC 3.16B 53M
Hikma Pharmaceutical HIK:LN 616M 5M
Lonza Group LONN:SW 1.04B 418M
Merck MRK:GR € 3114M 57M
Orion ORNBV:FH 130.6M 24.7M
Recordati REC:IM 278.29M 5.84M